← Home / BRIACELL THERAPEUTICS CORP. (BCTX)
Stock Analysis
BRIACELL THERAPEUTICS CORP. (BCTX)
BCTX
BCTX · Market data
2.80 -1.06%
52W Range Position
0%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-06-18 13:40 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
⚖️
Fundamentals
Insufficient / Insufficient
Price Structure
Vulnerable
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
Break Above
Confirmation improves above resistance.
3.62
🎯
Next Objective
Pattern-derived target if setup continues.
×
Thesis Break
Scenario weakens below invalidation.
Below —
What's Driving BCTX?
📈 Technical recovery is improving
Momentum is Neutral. Watch 3.62 for confirmation and for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
RSI(14)
33.7
Price Chart
BCTX · WOI overlay chart
Open Full Workspace
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
Revenue Growth
Insufficient
Profitability
Insufficient
Cash Flow
Pressured
Balance Sheet
Manageable
📈 Net Income
-7.16M
≈ Insufficient
🧮 EPS (Basic)
-0.99
≈ Insufficient
BRIACELL THERAPEUTICS CORP.
Note: This is an algorithmic technical snapshot, not financial advice.